Cybin announces results of shareholders' meeting

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeuticstm”, is pleased to announce the voting results for each of the matters presented at the company's annual meeting of shareholders held on august 15, 2022 (the “meeting”). there were 71 shareholders represented in person or by proxy at the meeting holding 47,019,721 common shares, representing 28.3% of cybin's total issued
CYBN Ratings Summary
CYBN Quant Ranking